LION BIOTECHNOLOGIES INC's ticker is LBIO and the CUSIP is 53619R102. A total of 79 filers reported holding LION BIOTECHNOLOGIES INC in Q1 2016. The put-call ratio across all filers is 0.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ayer Capital Management, LP | 2,823,333 | $25,890,000 | 96.51% |
| Avoro Capital Advisors LLC | 2,923,065 | $26,805,000 | 7.38% |
| ACUTA CAPITAL PARTNERS, LLC | 886,000 | $8,125,000 | 5.02% |
| Perceptive Advisors | 2,759,593 | $25,305,000 | 1.52% |
| Ghost Tree Capital, LLC | 350,000 | $3,210,000 | 1.04% |
| Broadfin Capital, LLC | 1,812,419 | $16,620,000 | 0.89% |
| P.A.W. CAPITAL CORP | 80,000 | $734,000 | 0.74% |
| Rhenman & Partners Asset Management AB | 556,000 | $5,099,000 | 0.61% |
| Cormorant Asset Management, LP | 499,815 | $4,583,000 | 0.61% |
| Trellus Management Company, LLC | 38,500 | $353,000 | 0.40% |